{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:11:30Z","timestamp":1780981890598,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFD1800304"],"award-info":[{"award-number":["2021YFD1800304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["21JR7RA019"],"award-info":[{"award-number":["21JR7RA019"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["21JR7RA019"],"award-info":[{"award-number":["21JR7RA019"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-025-13545-8","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:36:15Z","timestamp":1758940575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Foot-and-mouth disease vaccine with insertion of a 24-amino acid VP1 G-H loop epitope of the Cathay virus provides broad antigenic coverage"],"prefix":"10.1007","volume":"109","author":[{"given":"Keqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"13545_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.mi.22.100168.001221","volume":"22","author":"HL Bachrach","year":"1968","unstructured":"Bachrach HL (1968) Foot-and-mouth disease. Annu Rev Microbiol 22:201\u2013244. https:\/\/doi.org\/10.1146\/annurev.mi.22.100168.001221","journal-title":"Annu Rev Microbiol"},{"issue":"Pt 6","key":"13545_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1099\/0022-1317-70-6-1483","volume":"70","author":"PV Barnett","year":"1989","unstructured":"Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR (1989) Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol 70(Pt 6):1483\u20131491. https:\/\/doi.org\/10.1099\/0022-1317-70-6-1483","journal-title":"J Gen Virol"},{"issue":"2","key":"13545_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/jvi.74.2.987-991.2000","volume":"74","author":"CW Beard","year":"2000","unstructured":"Beard CW, Mason PW (2000) Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol 74(2):987\u2013991. https:\/\/doi.org\/10.1128\/jvi.74.2.987-991.2000","journal-title":"J Virol"},{"issue":"3","key":"13545_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0079-6107(93)90016-d","volume":"60","author":"GJ Belsham","year":"1993","unstructured":"Belsham GJ (1993) Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol 60(3):241\u2013260. https:\/\/doi.org\/10.1016\/0079-6107(93)90016-d","journal-title":"Prog Biophys Mol Biol"},{"issue":"9","key":"13545_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s10529-016-2121-4","volume":"38","author":"JK Biswal","year":"2016","unstructured":"Biswal JK, Ranjan R, Pattnaik B (2016) Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface. Biotechnol Lett 38(9):1509\u20131517. https:\/\/doi.org\/10.1007\/s10529-016-2121-4","journal-title":"Biotechnol Lett"},{"issue":"5869","key":"13545_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/298030a0","volume":"298","author":"JL Bittle","year":"1982","unstructured":"Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298(5869):30\u201333. https:\/\/doi.org\/10.1038\/298030a0","journal-title":"Nature"},{"issue":"13","key":"13545_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","volume":"26","author":"KE Brehm","year":"2008","unstructured":"Brehm KE, Kumar N, Thulke HH, Haas B (2008) High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26(13):1681\u20131687. https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.038","journal-title":"Vaccine"},{"issue":"2","key":"13545_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s0264-410x(88)80024-0","volume":"6","author":"F Brown","year":"1988","unstructured":"Brown F (1988) Use of peptides for immunization against foot-and-mouth disease. Vaccine 6(2):180\u2013182. https:\/\/doi.org\/10.1016\/s0264-410x(88)80024-0","journal-title":"Vaccine"},{"issue":"Pt 8","key":"13545_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1099\/0022-1317-74-8-1547","volume":"74","author":"JR Crowther","year":"1993","unstructured":"Crowther JR, Farias S, Carpenter WC, Samuel AR (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74(Pt 8):1547\u20131553. https:\/\/doi.org\/10.1099\/0022-1317-74-8-1547","journal-title":"J Gen Virol"},{"issue":"5\u20136","key":"13545_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0147-9571(02)00030-9","volume":"25","author":"G Davies","year":"2002","unstructured":"Davies G (2002) The foot and mouth disease (FMD) epidemic in the United Kingdom 2001. Comp Immunol Microbiol Infect Dis 25(5\u20136):331\u2013343. https:\/\/doi.org\/10.1016\/s0147-9571(02)00030-9","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4\u20135","key":"13545_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/15216540212657","volume":"53","author":"NL Davis","year":"2002","unstructured":"Davis NL, West A, Reap E, MacDonald G, Collier M, Dryga S, Maughan M, Connell M, Walker C, McGrath K, Cecil C, Ping LH, Frelinger J, Olmsted R, Keith P, Swanstrom R, Williamson C, Johnson P, Montefiori D, Johnston RE (2002) Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life 53(4\u20135):209\u2013211. https:\/\/doi.org\/10.1080\/15216540212657","journal-title":"IUBMB Life"},{"issue":"1","key":"13545_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0168-1702(02)00261-7","volume":"91","author":"TR Doel","year":"2003","unstructured":"Doel TR (2003) FMD vaccines. Virus Res 91(1):81\u201399. https:\/\/doi.org\/10.1016\/s0168-1702(02)00261-7","journal-title":"Virus Res"},{"issue":"3\u20134","key":"13545_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0378-1119(80)90073-6","volume":"11","author":"E Domingo","year":"1980","unstructured":"Domingo E, D\u00e1vila M, Ort\u00edn J (1980) Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11(3\u20134):333\u2013346. https:\/\/doi.org\/10.1016\/0378-1119(80)90073-6","journal-title":"Gene"},{"issue":"26","key":"13545_CR14","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.vaccine.2019.05.019","volume":"37","author":"I Fernandez-Sainz","year":"2019","unstructured":"Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los ST, Szczepanek SM (2019) The VP1 G-H loop hypervariable epitope contributes to protective immunity against foot and mouth disease virus in swine. Vaccine 37(26):3435\u20133442. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.019","journal-title":"Vaccine"},{"issue":"16","key":"13545_CR15","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1093\/nar\/12.16.6587","volume":"12","author":"S Forss","year":"1984","unstructured":"Forss S, Strebel K, Beck E, Schaller H (1984) Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12(16):6587\u20136601. https:\/\/doi.org\/10.1093\/nar\/12.16.6587","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"13545_CR16","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1016\/j.vaccine.2010.02.074","volume":"28","author":"VL Fowler","year":"2010","unstructured":"Fowler VL, Knowles NJ, Paton DJ, Barnett PV (2010) Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 28(19):3428\u20133434. https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.074","journal-title":"Vaccine"},{"issue":"2","key":"13545_CR17","first-page":"171","volume":"69","author":"MJ Francis","year":"1990","unstructured":"Francis MJ, Hastings GZ, Clarke BE, Brown AL, Beddell CR, Rowlands DJ, Brown F (1990) Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology 69(2):171\u2013176","journal-title":"Immunology"},{"key":"13545_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2021.105311","volume":"189","author":"H Gao","year":"2021","unstructured":"Gao H, Ma J (2021) Spatial distribution and risk areas of foot and mouth disease in mainland China. Prev Vet Med 189:105311. https:\/\/doi.org\/10.1016\/j.prevetmed.2021.105311","journal-title":"Prev Vet Med"},{"issue":"6","key":"13545_CR19","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1128\/jvi.62.6.2041-2049.1988","volume":"62","author":"F Gebauer","year":"1988","unstructured":"Gebauer F, de la Torre JC, Gomes I, Mateu MG, Barahona H, Tiraboschi B, Bergmann I, de Mello PA, Domingo E (1988) Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J Virol 62(6):2041\u20132049. https:\/\/doi.org\/10.1128\/jvi.62.6.2041-2049.1988","journal-title":"J Virol"},{"issue":"9","key":"13545_CR20","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1128\/jvi.03361-12","volume":"87","author":"AS Herbert","year":"2013","unstructured":"Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE, Stonier SW, Muhammad MA, Bakken RR, Prugar LI, Olinger GG, Groebner JL, Lee JS, Pratt WD, Custer M, Kamrud KI, Smith JF, Hart MK, Dye JM (2013) Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. J Virol 87(9):4952\u20134964. https:\/\/doi.org\/10.1128\/jvi.03361-12","journal-title":"J Virol"},{"issue":"1","key":"13545_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/viro.1998.9367","volume":"251","author":"M Hevey","year":"1998","unstructured":"Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A (1998) Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251(1):28\u201337. https:\/\/doi.org\/10.1006\/viro.1998.9367","journal-title":"Virology"},{"issue":"48","key":"13545_CR22","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1016\/j.vaccine.2007.09.038","volume":"25","author":"B Hubby","year":"2007","unstructured":"Hubby B, Talarico T, Maughan M, Reap EA, Berglund P, Kamrud KI, Copp L, Lewis W, Cecil C, Norberg P, Wagner J, Watson A, Negri S, Burnett BK, Graham A, Smith JF, Chulay JD (2007) Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 25(48):8180\u20138189. https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.038","journal-title":"Vaccine"},{"issue":"W1","key":"13545_CR23","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, Peters B, Nielsen M, Marcatili P (2017) BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res 45(W1):W24-w29. https:\/\/doi.org\/10.1093\/nar\/gkx346","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"13545_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0092-8674(82)90454-8","volume":"29","author":"AM King","year":"1982","unstructured":"King AM, McCahon D, Slade WR, Newman JW (1982) Recombination in RNA. Cell 29(3):921\u2013928. https:\/\/doi.org\/10.1016\/0092-8674(82)90454-8","journal-title":"Cell"},{"issue":"4","key":"13545_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0168-1702(85)90437-x","volume":"3","author":"AM King","year":"1985","unstructured":"King AM, McCahon D, Saunders K, Newman JW, Slade WR (1985) Multiple sites of recombination within the RNA genome of foot-and-mouth disease virus. Virus Res 3(4):373\u2013384. https:\/\/doi.org\/10.1016\/0168-1702(85)90437-x","journal-title":"Virus Res"},{"issue":"3\u20134","key":"13545_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","volume":"112","author":"TJ Knight-Jones","year":"2013","unstructured":"Knight-Jones TJ, Rushton J (2013) The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur? Prev Vet Med 112(3\u20134):161\u2013173. https:\/\/doi.org\/10.1016\/j.prevetmed.2013.07.013","journal-title":"Prev Vet Med"},{"issue":"1","key":"13545_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0168-1702(02)00260-5","volume":"91","author":"NJ Knowles","year":"2003","unstructured":"Knowles NJ, Samuel AR (2003) Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91(1):65\u201380. https:\/\/doi.org\/10.1016\/s0168-1702(02)00260-5","journal-title":"Virus Res"},{"issue":"3","key":"13545_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0264-410x(93)90199-8","volume":"11","author":"O Krebs","year":"1993","unstructured":"Krebs O, Ahl R, Straub OC, Marquardt O (1993) Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum. Vaccine 11(3):359\u2013362. https:\/\/doi.org\/10.1016\/0264-410x(93)90199-8","journal-title":"Vaccine"},{"key":"13545_CR29","doi-asserted-by":"publisher","unstructured":"Lee MJ, Jo H, Park SH, Ko MK, Kim SM, Kim B, Park JH (2020) Advanced foot-and-mouth disease vaccine platform for stimulation of simultaneous cellular and humoral immune responses. Vaccines (Basel) 8(2). https:\/\/doi.org\/10.3390\/vaccines8020254","DOI":"10.3390\/vaccines8020254"},{"issue":"1","key":"13545_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41541-022-00496-8","volume":"7","author":"MJ Lee","year":"2022","unstructured":"Lee MJ, Kim HM, Shin S, Jo H, Park SH, Kim SM, Park JH (2022) The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity. NPJ Vaccines 7(1):70. https:\/\/doi.org\/10.1038\/s41541-022-00496-8","journal-title":"NPJ Vaccines"},{"issue":"1","key":"13545_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13567-022-01072-7","volume":"53","author":"P Li","year":"2022","unstructured":"Li P, Huang S, Zha J, Sun P, Li D, Bao H, Cao Y, Bai X, Fu Y, Ma X, Li K, Yuan H, Zhang J, Zhao Z, Wang J, Zhang K, Chen Y, Zhang Q, Qi S, Liu Z, Lu Z (2022) Evaluation of immunogenicity and cross-reactive responses of vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle. Vet Res 53(1):56. https:\/\/doi.org\/10.1186\/s13567-022-01072-7","journal-title":"Vet Res"},{"key":"13545_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1147652","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Li Y, Ma J, Wu R, Zou X, Liu Y, Zhao Q, Zhu Y (2023) Molecular evolution, diversity, and adaptation of foot-and-mouth disease virus serotype O in Asia. Front Microbiol 14:1147652. https:\/\/doi.org\/10.3389\/fmicb.2023.1147652","journal-title":"Front Microbiol"},{"issue":"Pt 2","key":"13545_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1099\/vir.0.057521-0","volume":"95","author":"AB Ludi","year":"2014","unstructured":"Ludi AB, Horton DL, Li Y, Mahapatra M, King DP, Knowles NJ, Russell CA, Paton DJ, Wood JLN, Smith DJ, Hammond JM (2014) Antigenic variation of foot-and-mouth disease virus serotype A. J Gen Virol 95(Pt 2):384\u2013392. https:\/\/doi.org\/10.1099\/vir.0.057521-0","journal-title":"J Gen Virol"},{"issue":"8","key":"13545_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.vaccine.2018.12.064","volume":"37","author":"NA Lyons","year":"2019","unstructured":"Lyons NA, Knight-Jones TJD, Bartels C, Paton DJ, Ferrari G, Vermillion MS, Brooks AW, Motroni R, Parker E, Hefferin Berquist ML, Sumption KJ, Klement E (2019) Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines. Vaccine 37(8):1007\u20131015. https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.064","journal-title":"Vaccine"},{"issue":"7","key":"13545_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","volume":"17","author":"M Mahapatra","year":"2018","unstructured":"Mahapatra M, Parida S (2018) Foot and mouth disease vaccine strain selection: current approaches and future perspectives. Expert Rev Vaccines 17(7):577\u2013591. https:\/\/doi.org\/10.1080\/14760584.2018.1492378","journal-title":"Expert Rev Vaccines"},{"issue":"2\u20134","key":"13545_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.vetmic.2012.10.035","volume":"162","author":"E Maradei","year":"2013","unstructured":"Maradei E, Malirat V, Beascoechea CP, Benitez EO, Pedemonte A, Seki C, Novo SG, Balette CI, D\u2019Aloia R, La Torre JL, Mattion N, Toledo JR, Bergmann IE (2013) Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region. Vet Microbiol 162(2\u20134):479\u2013490. https:\/\/doi.org\/10.1016\/j.vetmic.2012.10.035","journal-title":"Vet Microbiol"},{"issue":"Pt 3","key":"13545_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1099\/0022-1317-71-3-629","volume":"71","author":"MG Mateu","year":"1990","unstructured":"Mateu MG, Mart\u00ednez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E (1990) A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol 71(Pt 3):629\u2013637. https:\/\/doi.org\/10.1099\/0022-1317-71-3-629","journal-title":"J Gen Virol"},{"issue":"3","key":"13545_CR38","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/jvi.68.3.1407-1417.1994","volume":"68","author":"MG Mateu","year":"1994","unstructured":"Mateu MG, Hern\u00e1ndez J, Mart\u00ednez MA, Feigelstock D, Lea S, P\u00e9rez JJ, Giralt E, Stuart D, Palma EL, Domingo E (1994) Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 68(3):1407\u20131417. https:\/\/doi.org\/10.1128\/jvi.68.3.1407-1417.1994","journal-title":"J Virol"},{"issue":"1","key":"13545_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0042-6822(95)80045-x","volume":"206","author":"MG Mateu","year":"1995","unstructured":"Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E (1995) Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206(1):298\u2013306. https:\/\/doi.org\/10.1016\/s0042-6822(95)80045-x","journal-title":"Virology"},{"issue":"6293","key":"13545_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/347569a0","volume":"347","author":"N Parry","year":"1990","unstructured":"Parry N, Fox G, Rowlands D, Brown F, Fry E, Acharya R, Logan D, Stuart D (1990) Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347(6293):569\u2013572. https:\/\/doi.org\/10.1038\/347569a0","journal-title":"Nature"},{"issue":"10","key":"13545_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0264-410x(92)90092-x","volume":"10","author":"TW Pay","year":"1992","unstructured":"Pay TW, Hingley PJ (1992) Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine 10(10):699\u2013706. https:\/\/doi.org\/10.1016\/0264-410x(92)90092-x","journal-title":"Vaccine"},{"issue":"11","key":"13545_CR42","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1128\/jvi.68.11.7092-7098.1994","volume":"68","author":"E Rieder","year":"1994","unstructured":"Rieder E, Baxt B, Lubroth J, Mason PW (1994) Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J Virol 68(11):7092\u20137098. https:\/\/doi.org\/10.1128\/jvi.68.11.7092-7098.1994","journal-title":"J Virol"},{"issue":"5944","key":"13545_CR43","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/306694a0","volume":"306","author":"DJ Rowlands","year":"1983","unstructured":"Rowlands DJ, Clarke BE, Carroll AR, Brown F, Nicholson BH, Bittle JL, Houghten RA, Lerner RA (1983) Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature 306(5944):694\u2013697. https:\/\/doi.org\/10.1038\/306694a0","journal-title":"Nature"},{"issue":"Pt 11","key":"13545_CR44","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1099\/vir.0.043521-0","volume":"93","author":"J Seago","year":"2012","unstructured":"Seago J, Jackson T, Doel C, Fry E, Stuart D, Harmsen MM, Charleston B, Juleff N (2012) Characterization of epitope-tagged foot-and-mouth disease virus. J Gen Virol 93(Pt 11):2371\u20132381. https:\/\/doi.org\/10.1099\/vir.0.043521-0","journal-title":"J Gen Virol"},{"issue":"Pt 7","key":"13545_CR45","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1099\/vir.0.052308-0","volume":"94","author":"J Seago","year":"2013","unstructured":"Seago J, Juleff N, Moffat K, Berryman S, Christie JM, Charleston B, Jackson T (2013) An infectious recombinant foot-and-mouth disease virus expressing a fluorescent marker protein. J Gen Virol 94(Pt 7):1517\u20131527. https:\/\/doi.org\/10.1099\/vir.0.052308-0","journal-title":"J Gen Virol"},{"issue":"2","key":"13545_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0042-6822(83)90258-1","volume":"128","author":"F Sobrino","year":"1983","unstructured":"Sobrino F, D\u00e1vila M, Ort\u00edn J, Domingo E (1983) Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128(2):310\u2013318. https:\/\/doi.org\/10.1016\/0042-6822(83)90258-1","journal-title":"Virology"},{"issue":"4","key":"13545_CR47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1128\/cvi.00035-12","volume":"19","author":"SM Szczepanek","year":"2012","unstructured":"Szczepanek SM, Barrette RW, Rood D, Alejo D, Silbart LK (2012) Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus. Clin Vaccine Immunol 19(4):461\u2013467. https:\/\/doi.org\/10.1128\/cvi.00035-12","journal-title":"Clin Vaccine Immunol"},{"issue":"21","key":"13545_CR48","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1128\/jvi.01254-12","volume":"86","author":"S Uddowla","year":"2012","unstructured":"Uddowla S, Hollister J, Pacheco JM, Rodriguez LL, Rieder E (2012) A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol 86(21):11675\u201311685. https:\/\/doi.org\/10.1128\/jvi.01254-12","journal-title":"J Virol"},{"issue":"2","key":"13545_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/lam.12354","volume":"60","author":"H Ullah","year":"2015","unstructured":"Ullah H, Siddique MA, Al Amin M, Das BC, Sultana M, Hossain MA (2015) Re-emergence of circulatory foot-and-mouth disease virus serotypes Asia1 in Bangladesh and VP1 protein heterogeneity with vaccine strain IND 63\/72. Lett Appl Microbiol 60(2):168\u2013173. https:\/\/doi.org\/10.1111\/lam.12354","journal-title":"Lett Appl Microbiol"},{"issue":"Pt 7","key":"13545_CR50","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1099\/vir.0.040253-0","volume":"93","author":"H Wang","year":"2012","unstructured":"Wang H, Xue M, Yang D, Zhou G, Wu D, Yu L (2012) Insertion of type O-conserved neutralizing epitope into the foot-and-mouth disease virus type Asia1 VP1 G-H loop: effect on viral replication and neutralization phenotype. J Gen Virol 93(Pt 7):1442\u20131448. https:\/\/doi.org\/10.1099\/vir.0.040253-0","journal-title":"J Gen Virol"},{"key":"13545_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2019.113786","volume":"276","author":"T Willems","year":"2020","unstructured":"Willems T, De Vleeschauwer A, Perez-Filgueira M, Li Y, Ludi A, Lefebvre D, Wilsden G, Statham B, Haas B, Mattion N, Robiolo B, Beascoechea Perez C, Maradei E, Smitsaart E, La Torre J, De Clercq K (2020) FMD vaccine matching: inter laboratory study for improved understanding of r(1) values. J Virol Methods 276:113786. https:\/\/doi.org\/10.1016\/j.jviromet.2019.113786","journal-title":"J Virol Methods"},{"key":"13545_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.vetmic.2017.04.023","volume":"205","author":"H Xu","year":"2017","unstructured":"Xu H, Bao X, Lu Y, Liu Y, Deng B, Wang Y, Xu Y, Hou J (2017) Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV). Vet Microbiol 205:46\u201352. https:\/\/doi.org\/10.1016\/j.vetmic.2017.04.023","journal-title":"Vet Microbiol"},{"key":"13545_CR53","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.virusres.2015.12.013","volume":"213","author":"B Yang","year":"2016","unstructured":"Yang B, Yang F, Zhang Y, Liu H, Jin Y, Cao W, Zhu Z, Zheng H, Yin H (2016) The rescue and evaluation of FLAG and HIS epitope-tagged Asia 1 type foot-and-mouth disease viruses. Virus Res 213:246\u2013254. https:\/\/doi.org\/10.1016\/j.virusres.2015.12.013","journal-title":"Virus Res"},{"issue":"13","key":"13545_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00588-19","volume":"93","author":"W Zhang","year":"2019","unstructured":"Zhang W, Yang F, Zhu Z, Yang Y, Wang Z, Cao W, Dang W, Li L, Mao R, Liu Y, Tian H, Zhang K, Liu X, Ma J, Zheng H (2019) Cellular DNAJA3, a novel VP1-interacting protein, inhibits foot-and-mouth disease virus replication by inducing lysosomal degradation of VP1 and attenuating its antagonistic role in the beta interferon signaling pathway. J Virol 93(13):e00588-19. https:\/\/doi.org\/10.1128\/jvi.00588-19","journal-title":"J Virol"},{"issue":"6","key":"13545_CR55","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1111\/tbed.12895","volume":"65","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Yang F, He J, Li J, Cao W, Li J, Xia Y, Guo J, Jin Y, Zhang K, Zheng H, Liu X (2018) First detection of foot-and-mouth disease virus O\/ME-SA\/Ind2001 in China. Transbound Emerg Dis 65(6):2027\u20132031. https:\/\/doi.org\/10.1111\/tbed.12895","journal-title":"Transbound Emerg Dis"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13545-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-025-13545-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-025-13545-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:32:12Z","timestamp":1770294732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-025-13545-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13545"],"URL":"https:\/\/doi.org\/10.1007\/s00253-025-13545-8","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Care and Use Committee (IACUC) of LVRI approved this study (No. LVRIAEC-2021\u2013040).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"206"}}